SPX3,585.62-54.85 -1.51%
DIA287.30-4.91 -1.68%
IXIC10,575.62-161.89 -1.51%

BRIEF-Immupharma PLC Says Currently Reviewing Written Response From FDA With Avion

BRIEF-Immupharma PLC Says Currently Reviewing Written Response From FDA With Avion

Reuters · 09/14/2022 05:27
BRIEF-Immupharma PLC Says Currently Reviewing Written Response From FDA With Avion

- ImmuPharma PLC IMM.L:

  • IMMUPHARMA PLC - WRITTEN RESPONSE RECEIVED FROM THE FDA

  • IMMUPHARMA PLC - CURRENTLY REVIEWING WRITTEN RESPONSE WITH AVION AND WILL MAKE A FURTHER NOTIFICATION IN DUE COURSE

  • IMMUPHARMA PLC - FDA RESPONSE INCLUDED ADVICE ON DOSING REGIME

  • IMMUPHARMA PLC - CO'S U.S. PARTNER FOR LUPUZOR (P140), AVION PHARMA GOT A WRITTEN RESPONSE FROM FDA TO TYPE C MEETING.

Source text for Eikon: ID:

Further company coverage: IMM.L


(Reporting by Prerna Bedi)

((Prerna.Bedi@thomsonreuters.com;))